Active substance
Results for the substance gilteritinib
1 result
About this active substance
Gilteritinib is a medication used for the treatment of acute myeloid leukemia (AML) in patients with FLT3 gene mutations. It is a tyrosine kinase inhibitor that blocks signals promoting cancer cell growth.
This medication is taken orally, usually once daily, as directed by a doctor. Gilteritinib helps slow disease progression and may improve patient survival.
Common side effects include fatigue, nausea, diarrhea, muscle pain, and elevated liver enzyme levels. In rare cases, severe reactions such as differentiation syndrome may occur.
It is important to follow your doctor's instructions closely and undergo regular tests to monitor treatment effectiveness and manage potential side effects.
This medication is taken orally, usually once daily, as directed by a doctor. Gilteritinib helps slow disease progression and may improve patient survival.
Common side effects include fatigue, nausea, diarrhea, muscle pain, and elevated liver enzyme levels. In rare cases, severe reactions such as differentiation syndrome may occur.
It is important to follow your doctor's instructions closely and undergo regular tests to monitor treatment effectiveness and manage potential side effects.